Rational: We retrospectively analyzed 232 patients affected by well differentiated ductal intraepithelial neoplasia (DIN1c or DCIS G1) treated with conservative surgery without adjuvant radiotherapy. Results: 25 invasive and 18 non-invasive local recurrences were observed ( median follow-up 80 months; 5-year cumulative incidence: 12.2%). Seven of the 15 young patients ( 7% (HR 2.33, 95% C.I. 1.20-4.55) and surgical margins <10 mm (HR 2.00, 95% C.I. 1.06-3.76) were significantly associated with an increased risk of local recurrence. Conclusions: Young age, multifocality and small margins appeared as clear risk factors of local recurrence in DIN1c (DCIS G1) population. The presence of multiple poor prognostic features warrant a thorough dis...
WOS: 000448315600003PubMed ID: 30121548Purpose: Turkish Radiation Oncology Study Group investigated ...
PURPOSE: Outcomes after different treatment strategies for ductal carcinoma in situ (DCIS) of the br...
Introduction Long-term survival is excellent in ductal Carcinoma in situ (DCIS); whether or not we ...
that may predict risks of recurrence in women with ductal carcinoma in situ (DCIS) have not been con...
Background: The main goal in treatment of ductal carcinoma-in-situ (DCIS) of the breast is to preve...
BACKGROUND: Clinical and histopathologic characteristics that may predict risks of recurrence in wom...
Background A previous study showed a 3% local recurrence risk at 8 years in ductal carcinoma in situ...
Background: It is not clear whether risk factors for local recurrence after breast-conserving surger...
Background: The aim of our study was to assess various predictors for local recurrence (LR) in patie...
Background: Breast-conserving surgery and axillary dissection followed by external beam radiation th...
Background: Local recurrence occurs in 10%–20% of patients treated with breast-conserving surgery fo...
Introduction. Diagnosis of breast ductal intraepithelial neoplasia (DIN) has increased over the last...
International audienceBACKGROUND:Tumour features associated with isolated invasive breast cancer (BC...
International audienceBACKGROUND: The objective of this retrospective study was to determine the inc...
BACKGROUND: The natural history of ductal carcinoma in situ (DCIS) remains uncertain. The risk facto...
WOS: 000448315600003PubMed ID: 30121548Purpose: Turkish Radiation Oncology Study Group investigated ...
PURPOSE: Outcomes after different treatment strategies for ductal carcinoma in situ (DCIS) of the br...
Introduction Long-term survival is excellent in ductal Carcinoma in situ (DCIS); whether or not we ...
that may predict risks of recurrence in women with ductal carcinoma in situ (DCIS) have not been con...
Background: The main goal in treatment of ductal carcinoma-in-situ (DCIS) of the breast is to preve...
BACKGROUND: Clinical and histopathologic characteristics that may predict risks of recurrence in wom...
Background A previous study showed a 3% local recurrence risk at 8 years in ductal carcinoma in situ...
Background: It is not clear whether risk factors for local recurrence after breast-conserving surger...
Background: The aim of our study was to assess various predictors for local recurrence (LR) in patie...
Background: Breast-conserving surgery and axillary dissection followed by external beam radiation th...
Background: Local recurrence occurs in 10%–20% of patients treated with breast-conserving surgery fo...
Introduction. Diagnosis of breast ductal intraepithelial neoplasia (DIN) has increased over the last...
International audienceBACKGROUND:Tumour features associated with isolated invasive breast cancer (BC...
International audienceBACKGROUND: The objective of this retrospective study was to determine the inc...
BACKGROUND: The natural history of ductal carcinoma in situ (DCIS) remains uncertain. The risk facto...
WOS: 000448315600003PubMed ID: 30121548Purpose: Turkish Radiation Oncology Study Group investigated ...
PURPOSE: Outcomes after different treatment strategies for ductal carcinoma in situ (DCIS) of the br...
Introduction Long-term survival is excellent in ductal Carcinoma in situ (DCIS); whether or not we ...